Cathay Biotech Inc. (688065.SH) plans to distribute CNY 1.9 per 10 shares for 2023, ex-rights and ex-dividend on July 24th.

Cathay Biotech Inc. (688065.SH) announced that it plans to distribute cash to all shareholders at a rate of 10 shares per share for the year 2023.

Zhitong FinanceJul 17 06:29 ET

Is Cathay Biotech (SHSE:688065) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be

Simply Wall StJul 12 18:47 ET

Cathay Biotech Inc. (688065.SH): Shareholder Tianjin Sitoon and consistent actors have cumulatively reduced their shareholding by 1.518% in the company.

Cathay Biotech Inc. (688065.SH) announced on July 10 that it had received a notice letter issued by shareholder Tianjin Sitoon and concerted action Seasource on July 10, 2024. As of the disclosure date of this announcement, Tianjin Sitoon and Seasource have collectively reduced their holdings of the company's shares by 8,856,696 shares through a bulk trading method during the current shareholding reduction period, the reduction ratio of which accounted for 1.518% of the company's total share capital. Among them: Tianjin Sitoon reduced its holdings of the company's shares by 8,656,696 shares through bulk trading, the reduction ratio of which accounted for 1.48% of the company's total share capital.

Gelonghui FinanceJul 10 06:05 ET

Cathay Biotech Inc. (688065.SH): accumulated buyback of 0.1629% of shares.

Cathay Biotech Inc. (688065.SH) announced on July 1st that as of June 30th, 2024, the company repurchased 950,464 shares of the company's stock through the Shanghai Stock Exchange trading system with a centralized bidding trading method, accounting for 0.1629% of the company's total share capital of 583,378,039 shares. The highest price for repurchase was 57.37 yuan/share and the lowest was 38.98 yuan/share, with a total amount of CNY 49,415,764.27 (excluding stamp duty, transaction commissions and other transaction costs).

Gelonghui FinanceJul 1 05:24 ET

Some Investors May Be Worried About Cathay Biotech's (SHSE:688065) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Typically, we'll want to notice a trend of growing return on capital employed (RO

Simply Wall StMay 27 02:10 ET

Tianjin Sitong, the shareholder of Kaisai Biotech (688065.SH), and its co-actors reduced their holdings by 4.921,000 shares

Zhitong Finance App News, Kaisai Biotech (688065.SH) issued an announcement. On May 24, 2024, the company received the “Notice Letter on the Halfway Reduction of Shares and the Progress of Shareholding Reduction” from the shareholder Tianjin Sitong Longtongyuan Enterprise Management Partnership (“Tianjin Sitong”) and its co-actor Seasource Holdings Limited (“Seasource”). As of the disclosure date of this announcement, the current holdings reduction plan has passed halfway. Tianjin Sitong and its co-actors Seasource through a major counterparty

Zhitong FinanceMay 24 05:16 ET